COVID-19's Effect on the Enteric Disease Testing Market in 2021: Industry Size, Latest Trends, Global Growth, and Forecast Research Report 2027

 

Enteric Disease Testing Market


Enteric sicknesses are brought about by miniature creatures like parasites, microbes, and infections that reason intestinal disease. Enteric sickness is brought about by microorganisms that are found inside the small digestive system. The term enteric depicts the region where these microscopic organisms append to the coating of the small digestive system, and it is by and large idea that there are around 500 distinct strains of this kind of microbes.
An individual isn't really in danger of creating enteric illness, however the individuals who have a family background of the sickness are especially in danger. Enteric infections frequently come about because of devouring defiled water or food and some can spread from one individual to another.
The emergence of COVID-19 (the novel coronavirus) is expected to propel the growth of the enteric disease testing market. For instance, according to the World Health Organization (WHO), worldwide, as of 5:01pm CET, 11 February 2021, there have been 106,991,090 confirmed cases of COVID-19, including 2,347,015 deaths.

Increasing prevalence of enteric diseases worldwide and increasing launches and approvals of new products are expected to drive the enteric disease testing market growth. For instance, in October 2019, Mobidiag received CE-IVD marking for its Novodiag Stool Parasites test for the detection of intestinal parasites from stool samples.


No comments:

Post a Comment